Non-human primate studies play a pivotal role in the biomedical research landscape, particularly in evaluating the safety and efficacy of new therapies. As a leading Contract Research Organization (CRO), InfinixBio supports life sciences firms in utilizing the unique advantages of non-human primate studies in their drug development process. This article explores the significance of these studies, their applications, and how they facilitate accelerated drug development.
Non-human primate studies refer to research conducted using primates such as monkeys and apes to model human diseases and therapeutic responses. These studies provide invaluable insights due to the close genetic, physiological, and social similarities between non-human primates and humans.
Non-human primate studies provide essential support across various stages of the drug development lifecycle. Below are key applications:
Before a new drug can be tested in humans, it must undergo Investigational New Drug (IND)-enabling studies. Non-human primates are instrumental in these studies as they help assess the safety and biological activity of the drug.
These studies are often required to demonstrate the efficacy of a drug before entering clinical trials. Non-human primates allow researchers to examine the therapeutic effects in a living system closely related to humans.
Understanding a drug’s potential to elicit an immune response is crucial. Non-human primate studies, including immunogenicity testing, ensure that therapeutic candidates maintain safety and effectiveness in humans.
At InfinixBio, we offer expert support in non-human primate studies, ensuring that our clients achieve their drug development goals efficiently. Here are the key advantages of collaborating with us:
Non-human primate studies are regulated by animal welfare laws and guidelines, including the Animal Welfare Act (AWA) and the National Institutes of Health (NIH) guidelines, ensuring ethical treatment.
These studies typically involve a structured protocol outlining the study design, objectives, and endpoints, followed by the careful selection and use of non-human primates to maximize the relevance of the findings.
They provide critical insights into the potential human response to therapeutic candidates, ensuring that safety and efficacy are thoroughly evaluated before progressing to human clinical trials.
To explore our full range of services, including our specialized non-human primate studies, contact us today to see how InfinixBio can assist in your drug development journey.
Non-human primate studies are an essential component of modern drug development, offering unique insights that enhance the safety and efficacy of therapeutics. By partnering with InfinixBio, you can leverage our expertise to navigate the complexities of these studies and accelerate your drug development path. For more information on how we can support your research needs, contact us today.
Our experienced lab team is here to help. Reach out today to learn more.